Leon J. Thal, MD - Publications

Affiliations: 
Neuroscience University of California, San Diego, La Jolla, CA 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=27
Website:
http://ucsdnews.ucsd.edu/newsrel/health/thal07.asp

314 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Ayton S, Faux NG, Bush AI. Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nature Communications. 6: 6760. PMID 25988319 DOI: 10.1038/ncomms7760  0.68
2011 Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR, Thal L, Aisen PS, et al. Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. Archives of General Psychiatry. 68: 853-61. PMID 21810649 DOI: 10.1001/archgenpsychiatry.2011.72  0.68
2010 Rapp SR, Legault C, Henderson VW, Brunner RL, Masaki K, Jones B, Absher J, Thal L. Subtypes of mild cognitive impairment in older postmenopausal women: the Women's Health Initiative Memory Study. Alzheimer Disease and Associated Disorders. 24: 248-55. PMID 20473134 DOI: 10.1097/WAD.0b013e3181d715d5  0.68
2010 Apostolova LG, Thompson PM, Green AE, Hwang KS, Zoumalan C, Jack CR, Harvey DJ, Petersen RC, Thal LJ, Aisen PS, Toga AW, Cummings JL, Decarli CS. 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Human Brain Mapping. 31: 786-97. PMID 20143386 DOI: 10.1002/hbm.20905  0.68
2009 Vellas B, Black R, Thal LJ, Fox NC, Daniels M, McLennan G, Tompkins C, Leibman C, Pomfret M, Grundman M. Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Current Alzheimer Research. 6: 144-51. PMID 19355849 DOI: 10.2174/156720509787602852  0.68
2008 Hamilton JM, Salmon DP, Galasko D, Raman R, Emond J, Hansen LA, Masliah E, Thal LJ. Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology. 22: 729-37. PMID 18999346 DOI: 10.1037/a0012949  0.68
2008 Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. Jama. 300: 1774-83. PMID 18854539 DOI: 10.1001/jama.300.15.1774  0.68
2008 van Straaten EC, Harvey D, Scheltens P, Barkhof F, Petersen RC, Thal LJ, Jack CR, DeCarli C. Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. Journal of Neurology. 255: 1302-8. PMID 18825439 DOI: 10.1007/s00415-008-0874-y  0.68
2008 Fleisher AS, Raman R, Siemers ER, Becerra L, Clark CM, Dean RA, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Sherzai A, Sowell BB, Aisen PS, Thal LJ. Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Archives of Neurology. 65: 1031-8. PMID 18695053 DOI: 10.1001/archneur.65.8.1031  0.68
2008 Fine EM, Delis DC, Wetter SR, Jacobson MW, Jak AJ, McDonald CR, Braga JC, Thal LJ, Salmon DP, Bondi MW. Cognitive discrepancies versus APOE genotype as predictors of cognitive decline in normal-functioning elderly individuals: a longitudinal study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 366-74. PMID 18448849 DOI: 10.1097/JGP.0b013e3181629957  0.68
2008 Aisen PS, Thal LJ, Ferris SH, Assaid C, Nessly ML, Giuliani MJ, Lines CR, Norman BA, Potter WZ. Rofecoxib in patients with mild cognitive impairment: further analyses of data from a randomized, double-blind, trial. Current Alzheimer Research. 5: 73-82. PMID 18288935 DOI: 10.2174/156720508783884602  0.68
2008 Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR, Aisen PS, Thal LJ. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology. 70: 191-9. PMID 18195264 DOI: 10.1212/01.wnl.0000287091.57376.65  0.68
2008 Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R, Jones L, Catanese J, Ross D, Mayo K, Martinez M, Hollingworth P, Goate A, Cairns NJ, Racette BA, ... ... Thal LJ, et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Human Molecular Genetics. 17: 759-67. PMID 18063669 DOI: 10.1093/hmg/ddm348  0.68
2008 Delano-Wood L, Houston WS, Emond JA, Marchant NL, Salmon DP, Jeste DV, Thal LJ, Bondi MW. APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study. International Journal of Geriatric Psychiatry. 23: 632-6. PMID 18058831 DOI: 10.1002/gps.1953  0.68
2008 Jack CR, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Sencakova D, Doody RS, Thal LJ. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiology of Aging. 29: 1285-95. PMID 17452062 DOI: 10.1016/j.neurobiolaging.2007.03.004  0.68
2008 Weisman DC, Taylor C, Adame A, Thal LJ, Hansen LA. Reply from the authors Neurology. 70: 2088-2089. DOI: 10.1212/01.wnl.0000315887.53460.29  0.68
2007 Thal L, Kuller L, Bowman K, Breitner J, Evans D, Farrer L, Frank R, Khachaturian AS, Khachaturian ZS, Kukull W, Nieto J, Petersen R, Sager M, Scherr P, Bain LJ. The Nevada Vital Aging Initiative: a private-public partnership to study early predictors of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 62-7. PMID 19595919 DOI: 10.1016/j.jalz.2006.11.002  0.68
2007 Fennema-Notestine C, Gamst AC, Quinn BT, Pacheco J, Jernigan TL, Thal L, Buckner R, Killiany R, Blacker D, Dale AM, Fischl B, Dickerson B, Gollub RL. Feasibility of multi-site clinical structural neuroimaging studies of aging using legacy data. Neuroinformatics. 5: 235-45. PMID 17999200 DOI: 10.1007/s12021-007-9003-9  0.68
2007 Mickes L, Wixted JT, Fennema-Notestine C, Galasko D, Bondi MW, Thal LJ, Salmon DP. Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease. Neuropsychology. 21: 696-705. PMID 17983283 DOI: 10.1037/0894-4105.21.6.696  0.68
2007 Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, Hubbard JL, Koepsell TD, Morris JC, Kukull WA, Reiman EM, Kowall N, Landreth G, Shelanski M, Welsh-Bohmer K, ... ... Thal LJ, et al. The National Alzheimer's Coordinating Center (NACC) database: The uniform data set Alzheimer Disease and Associated Disorders. 21: 249-258. PMID 17804958 DOI: 10.1097/WAD.0b013e318142774e  0.68
2007 Weisman D, Cho M, Taylor C, Adame A, Thal LJ, Hansen LA. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology. 69: 356-9. PMID 17646627 DOI: 10.1212/01.wnl.0000266626.64913.0f  0.68
2007 Galasko D, Salmon D, Gamst A, Olichney J, Thal LJ, Silbert L, Kaye J, Brooks P, Adonay R, Craig UK, Schellenberg G, Borenstein AR. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Neurology. 68: 1772-81. PMID 17515539 DOI: 10.1212/01.wnl.0000262028.16738.64  0.68
2007 Borenstein AR, Mortimer JA, Schofield E, Wu Y, Salmon DP, Gamst A, Olichney J, Thal LJ, Silbert L, Kaye J, Craig UL, Schellenberg GD, Galasko DR. Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Neurology. 68: 1764-71. PMID 17515538 DOI: 10.1212/01.wnl.0000262027.31623.b2  0.68
2007 Weisman DC, Yaari R, Hansen LA, Thal LJ. Density of the brain, decline of the mind: an atypical case of Fahr disease. Archives of Neurology. 64: 756-7. PMID 17502478 DOI: 10.1001/archneur.64.5.756  0.68
2007 Kurlan R, Cummings J, Raman R, Thal L. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism Neurology. 68: 1356-1363. PMID 17452579 DOI: 10.1212/01.wnl.0000260060.60870.89  0.68
2007 Wahrle SE, Shah AR, Fagan AM, Smemo S, Kauwe JS, Grupe A, Hinrichs A, Mayo K, Jiang H, Thal LJ, Goate AM, Holtzman DM. Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. Molecular Neurodegeneration. 2: 7. PMID 17430597 DOI: 10.1186/1750-1326-2-7  0.68
2007 Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A, Jehu L, Segurado R, Stone D, Schadt E, Karnoub M, Nowotny P, Tacey K, Catanese J, Sninsky J, ... ... Thal L, et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Human Molecular Genetics. 16: 865-73. PMID 17317784 DOI: 10.1093/hmg/ddm031  0.68
2007 Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology. 68: 1588-95. PMID 17287448 DOI: 10.1212/01.wnl.0000258542.58725.4c  0.68
2007 Frielingsdorf H, Simpson DR, Thal LJ, Pizzo DP. Nerve growth factor promotes survival of new neurons in the adult hippocampus. Neurobiology of Disease. 26: 47-55. PMID 17270453 DOI: 10.1016/j.nbd.2006.11.015  0.68
2007 DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack CR, Scheltens P. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Archives of Neurology. 64: 108-15. PMID 17210817 DOI: 10.1001/archneur.64.1.108  0.68
2007 Rascovsky K, Salmon DP, Hansen LA, Thal LJ, Galasko D. Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology. 21: 20-30. PMID 17201527 DOI: 10.1037/0894-4105.21.1.20  0.68
2007 Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG, Corey-Bloom J, Salmon DP, Thal LJ, Bondi MW. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiology of Aging. 28: 238-47. PMID 16434125 DOI: 10.1016/j.neurobiolaging.2005.12.013  0.68
2006 Beal MF, Bossy-Wetzel E, Finkbeiner S, Fiskum G, Giasson B, Johnson C, Khachaturian ZS, Lee VM, Nicholls D, Reddy H, Reynolds I, Teplow DB, Thal LJ, Trojanowski JQ, Walsh DM, et al. Common threads in neurodegenerative disorders of aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 322-6. PMID 19595906 DOI: 10.1016/j.jalz.2006.08.008  0.68
2006 Grundman M, Petersen RC, Bennett DA, Feldman HH, Salloway S, Visser PJ, Thal LJ, Schenk D, Khachaturian Z, Thies W. Alzheimer's Association Research Roundtable Meeting on Mild Cognitive Impairment: what have we learned? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 220-33. PMID 19595891 DOI: 10.1016/j.jalz.2006.04.010  0.68
2006 Yaari R, Fleisher AS, Gamst AC, Bagwell VP, Thal LJ. Utility of the telephone interview for cognitive status for enrollment in clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 104-9. PMID 19595866 DOI: 10.1016/j.jalz.2006.02.004  0.68
2006 Sano M, Zhu CW, Whitehouse PJ, Edland S, Jin S, Ernstrom K, Thomas RG, Thal LJ, Ferris SH. ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly. Alzheimer Disease and Associated Disorders. 20: S191-202. PMID 17135812 DOI: 10.1097/01.wad.0000213875.63171.87  0.68
2006 Salmon DP, Cummings JL, Jin S, Sano M, Sperling RA, Zamrini E, Petersen RC, Edland SD, Thal LJ, Ferris SH. ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials. Alzheimer Disease and Associated Disorders. 20: S139-46. PMID 17135807 DOI: 10.1097/01.wad.0000213871.40300.68  0.68
2006 Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ. ADCS Prevention Instrument Project: overview and initial results. Alzheimer Disease and Associated Disorders. 20: S109-23. PMID 17135805 DOI: 10.1097/01.wad.0000213870.40300.21  0.68
2006 Sano M, Egelko S, Jin S, Cummings J, Clark CM, Pawluczyk S, Thomas RJ, Schittini M, Thal LJ. Spanish instrument protocol: new treatment efficacy instruments for Spanish-speaking patients in Alzheimer disease clinical trials. Alzheimer Disease and Associated Disorders. 20: 232-41. PMID 17132967 DOI: 10.1097/01.wad.0000213862.20108.f5  0.68
2006 Thal LJ. Prevention of Alzheimer disease. Alzheimer Disease and Associated Disorders. 20: S97-9. PMID 16917204 DOI: 10.1097/00002093-200607001-00015  0.68
2006 Thal LJ, Kawas C, Galasko D, Salmon DP, Sundsmo MP. Robert Katzman honored. Alzheimer Disease and Associated Disorders. 20: S27-8. PMID 16917190 DOI: 10.1097/00002093-200607001-00001  0.68
2006 Li Y, Grupe A, Rowland C, Nowotny P, Kauwe JS, Smemo S, Hinrichs A, Tacey K, Toombs TA, Kwok S, Catanese J, White TJ, Maxwell TJ, Hollingworth P, Abraham R, ... ... Thal LJ, et al. DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Human Molecular Genetics. 15: 2560-8. PMID 16847012 DOI: 10.1093/hmg/ddl178  0.68
2006 Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, Zetterberg H, Galasko D, Praticò D, Griffin S, Schenk D, Siemers E. The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Disease and Associated Disorders. 20: 6-15. PMID 16493230 DOI: 10.1097/01.wad.0000191420.61260.a8  0.68
2006 Webster B, Hansen L, Adame A, Crews L, Torrance M, Thal L, Masliah E. Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 65: 142-51. PMID 16462205 DOI: 10.1097/01.jnen.0000199599.63204.6f  0.68
2006 Elson JL, Herrnstadt C, Preston G, Thal L, Morris CM, Edwardson JA, Beal MF, Turnbull DM, Howell N. Does the mitochondrial genome play a role in the etiology of Alzheimer's disease? Human Genetics. 119: 241-54. PMID 16408223 DOI: 10.1007/s00439-005-0123-8  0.68
2006 Tiraboschi P, Salmon DP, Hansen LA, Hofstetter RC, Thal LJ, Corey-Bloom J. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain : a Journal of Neurology. 129: 729-35. PMID 16401618 DOI: 10.1093/brain/awh725  0.68
2006 Grupe A, Li Y, Rowland C, Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell TJ, Cherny S, Doil L, Tacey K, van Luchene R, Myers A, Wavrant-De Vrièze F, Kaleem M, ... ... Thal L, et al. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. American Journal of Human Genetics. 78: 78-88. PMID 16385451 DOI: 10.1086/498851  0.68
2006 Frielingsdorf H, Thal LJ, Pizzo DP. The septohippocampal cholinergic system and spatial working memory in the Morris water maze. Behavioural Brain Research. 168: 37-46. PMID 16330106 DOI: 10.1016/j.bbr.2005.10.008  0.68
2006 Smemo S, Nowotny P, Hinrichs AL, Kauwe JS, Cherny S, Erickson K, Myers AJ, Kaleem M, Marlowe L, Gibson AM, Hollingworth P, O'Donovan MC, Morris CM, Holmans P, Lovestone S, ... ... Thal L, et al. Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease. Annals of Neurology. 59: 21-6. PMID 16278862 DOI: 10.1002/ana.20673  0.68
2006 Pizzo DP, Coufal NG, Lortie MJ, Gage FH, Thal LJ. Regulatable acetylcholine-producing fibroblasts enhance cognitive performance. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 175-82. PMID 16185935 DOI: 10.1016/j.ymthe.2005.08.001  0.68
2006 Fleischer A, Jack CR, Petersen RC, Edland S, Thal LJ. APOE-E4 status, hippocampal volume and gender differences in mild cognitive impairment Research and Practice in Alzheimer's Disease. 11: 167-173.  0.68
2006 Vellas B, Thal L. Prevention trials in the field of Alzheimer disease Neurology. 67: S1.  0.68
2005 Thal LJ. Reminiscences: Robert Katzman and Robert Terry. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 1: 73. PMID 19595821 DOI: 10.1016/j.jalz.2005.06.009  0.68
2005 Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 1: 55-66. PMID 17476317 DOI: 10.1016/j.jalz.2005.06.003  0.68
2005 Gozes I, Morimoto BH, Tiong J, Fox A, Sutherland K, Dangoor D, Holser-Cochav M, Vered K, Newton P, Aisen PS, Matsuoka Y, van Dyck CH, Thal L. NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). Cns Drug Reviews. 11: 353-68. PMID 16614735  0.68
2005 Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clinics of North America. 15: 869-77, xi-xii. PMID 16443497 DOI: 10.1016/j.nic.2005.09.008  0.68
2005 Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, Bondi MW. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Archives of Neurology. 62: 1881-8. PMID 16344346 DOI: 10.1001/archneur.62.12.1881  0.68
2005 Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L. Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: A randomized, controlled trial American Journal of Geriatric Psychiatry. 13: 942-949. PMID 16286437 DOI: 10.1097/00019442-200511000-00004  0.68
2005 Olichney JM, Murphy C, Hofstetter CR, Foster K, Hansen LA, Thal LJ, Katzman R. Anosmia is very common in the Lewy body variant of Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1342-7. PMID 16170073 DOI: 10.1136/jnnp.2003.032003  0.68
2005 Barnes DE, Yaffe K, Petersen RC, Thomas RG, Thal LJ. Vitamin E and donepezil for the treatment of mild cognitive impairment [1] (multiple letter) New England Journal of Medicine. 353: 951-952. PMID 16135844 DOI: 10.1056/NEJMc051856  0.68
2005 Wu CK, Thal L, Pizzo D, Hansen L, Masliah E, Geula C. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease Experimental Neurology. 195: 484-496. PMID 16085017 DOI: 10.1016/j.expneurol.2005.06.020  0.68
2005 Palmer BW, Dunn LB, Appelbaum PS, Mudaliar S, Thal L, Henry R, Golshan S, Jeste DV. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Archives of General Psychiatry. 62: 726-33. PMID 15997013 DOI: 10.1001/archpsyc.62.7.726  0.68
2005 Li Y, Rowland C, Tacey K, Catanese J, Sninsky J, Hardy J, Powell J, Lovestone S, Morris JC, Thal L, Goate A, Owen M, Williams J, Grupe A. The BDNF Val66Met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples. Molecular Psychiatry. 10: 809-10. PMID 15970929 DOI: 10.1038/sj.mp.4001702  0.68
2005 Fleisher A, Grundman M, Jack CR, Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, Thal LJ. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Archives of Neurology. 62: 953-7. PMID 15956166 DOI: 10.1001/archneur.62.6.953  0.68
2005 Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell T, Holmans P, Hamshere M, Turic D, Jehu L, Hollingworth P, Moore P, Bryden L, Myers A, Doil LM, Tacey KM, ... ... Thal L, et al. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 136: 62-8. PMID 15858813 DOI: 10.1002/ajmg.b.30186  0.68
2005 Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nature Medicine. 11: 551-5. PMID 15852017 DOI: 10.1038/nm1239  0.68
2005 Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ. Vitamin E and donepezil for the treatment of mild cognitive impairment. The New England Journal of Medicine. 352: 2379-88. PMID 15829527 DOI: 10.1056/NEJMoa050151  0.68
2005 Sabbagh MN, Tyas SL, Emery SC, Hansen LA, Alford MF, Reid RT, Tiraboschi P, Thal LJ. Smoking affects the phenotype of Alzheimer disease. Neurology. 64: 1301-3. PMID 15824373 DOI: 10.1212/01.WNL.0000156912.54593.65  0.68
2005 Tractenberg RE, Weiner MF, Cummings JL, Patterson MB, Thal LJ. Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach. The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 51-60. PMID 15746483 DOI: 10.1176/appi.neuropsych.17.1.51  0.68
2005 Thal LJ, Ferris SH, Kirby L, Block GA, Lines CR, Yuen E, Assaid C, Nessly ML, Norman BA, Baranak CC, Reines SA. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1204-15. PMID 15742005 DOI: 10.1038/sj.npp.1300690  0.68
2005 Li Y, Hollingworth P, Moore P, Foy C, Archer N, Powell J, Nowotny P, Holmans P, O'Donovan M, Tacey K, Doil L, van Luchene R, Garcia V, Rowland C, Lau K, ... ... Thal L, et al. Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease. Human Mutation. 25: 270-7. PMID 15714520 DOI: 10.1002/humu.20138  0.68
2005 Ho GJ, Hashimoto M, Adame A, Izu M, Alford MF, Thal LJ, Hansen LA, Masliah E. Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role. Neurobiology of Aging. 26: 625-35. PMID 15708437 DOI: 10.1016/j.neurobiolaging.2004.06.016  0.68
2005 Thal L. Alzheimer's Disease Cooperative Study (ADCS): Overview Research and Practice in Alzheimer's Disease. 10: 25-33.  0.68
2004 Cummings JL, Tractenberg RE, Gamst A, Teri L, Masterman D, Thal LJ. Regression to the mean: implications for clinical trials of psychotropic agents in dementia. Current Alzheimer Research. 1: 323-8. PMID 15975061  0.68
2004 Schafer KA, Tractenberg RE, Sano M, Mackell JA, Thomas RG, Gamst A, Thal LJ, Morris JC. Reliability of monitoring the clinical dementia rating in multicenter clinical trials. Alzheimer Disease and Associated Disorders. 18: 219-22. PMID 15592134  0.68
2004 Thal LJ. The Alzheimer's Disease Cooperative Study in 2004. Alzheimer Disease and Associated Disorders. 18: 183-5. PMID 15592126  0.68
2004 Li Y, Nowotny P, Holmans P, Smemo S, Kauwe JS, Hinrichs AL, Tacey K, Doil L, van Luchene R, Garcia V, Rowland C, Schrodi S, Leong D, Gogic G, Chan J, ... ... Thal L, et al. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proceedings of the National Academy of Sciences of the United States of America. 101: 15688-93. PMID 15507493 DOI: 10.1073/pnas.0403535101  0.68
2004 Hamilton JM, Salmon DP, Galasko D, Delis DC, Hansen LA, Masliah E, Thomas RG, Thal LJ. A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 10: 689-97. PMID 15327716 DOI: 10.1017/S1355617704105043  0.68
2004 Li Y, Tacey K, Doil L, van Luchene R, Garcia V, Rowland C, Schrodi S, Leong D, Lau K, Catanese J, Sninsky J, Nowotny P, Holmans P, Hardy J, Powell J, ... ... Thal L, et al. Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neuroscience Letters. 366: 268-71. PMID 15288432 DOI: 10.1016/j.neulet.2004.05.047  0.68
2004 Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study Journal of the American Medical Association. 291: 2947-2958. PMID 15213206 DOI: 10.1001/jama.291.24.2947  0.68
2004 Pizzo DP, Paban V, Coufal NG, Gage FH, Thal LJ. Long-term production of choline acetyltransferase in the CNS after transplantation of fibroblasts modified with a regulatable vector. Brain Research. Molecular Brain Research. 126: 1-13. PMID 15207910 DOI: 10.1016/j.molbrainres.2004.03.006  0.68
2004 Licastro F, Chiappelli M, Thal LJ, Masliah E. alpha-1-Antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease. Archives of Gerontology and Geriatrics. Supplement. 243-51. PMID 15207421 DOI: 10.1016/j.archger.2004.04.034  0.68
2004 Brandon EP, Mellott T, Pizzo DP, Coufal N, D'Amour KA, Gobeske K, Lortie M, López-Coviella I, Berse B, Thal LJ, Gage FH, Blusztajn JK. Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5459-66. PMID 15201317 DOI: 10.1523/JNEUROSCI.1106-04.2004  0.68
2004 Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology. 62: 1984-9. PMID 15184601  0.68
2004 Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology. 62: 1977-83. PMID 15184600  0.68
2004 Swanberg MM, Tractenberg RE, Mohs R, Thal LJ, Cummings JL. Executive dysfunction in Alzheimer disease. Archives of Neurology. 61: 556-60. PMID 15096405 DOI: 10.1001/archneur.61.4.556  0.68
2004 Tiraboschi P, Sabbagh MN, Hansen LA, Salmon DP, Merdes A, Gamst A, Masliah E, Alford M, Thal LJ, Corey-Bloom J. Alzheimer disease without neocortical neurofibrillary tangles: "a second look". Neurology. 62: 1141-7. PMID 15079014  0.68
2004 Pizzo DP, Thal LJ. Intraparenchymal nerve growth factor improves behavioral deficits while minimizing the adverse effects of intracerebroventricular delivery. Neuroscience. 124: 743-55. PMID 15026115 DOI: 10.1016/j.neuroscience.2003.12.041  0.68
2004 Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, ... ... Thal LJ, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Archives of Neurology. 61: 59-66. PMID 14732621 DOI: 10.1001/archneur.61.1.59  0.68
2003 Thal LJ, Grundman M, Berg J, Ernstrom K, Margolin R, Pfeiffer E, Weiner MF, Zamrini E, Thomas RG. Idebenone treatment fails to slow cognitive decline in Alzheimer's disease. Neurology. 61: 1498-502. PMID 14663031  0.68
2003 Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep. 26: 893-901. PMID 14655926  0.68
2003 Tractenberg RE, Singer CM, Cummings JL, Thal LJ. The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease. Journal of Sleep Research. 12: 331-7. PMID 14633245  0.68
2003 Caligiuri MP, Peavy G, Salmon DP, Galasko DR, Thal LJ. Neuromotor abnormalities and risk for psychosis in Alzheimer's disease. Neurology. 61: 954-8. PMID 14557567  0.68
2003 Brinton RD, Nilsen J. Effects of estrogen plus progestin on risk of dementia. Jama. 290: 1706; author reply 1. PMID 14519699 DOI: 10.1001/jama.290.13.1706-a  0.68
2003 Grundman M, Jack CR, Petersen RC, Kim HT, Taylor C, Datvian M, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Darvesh S, Yaffe K, Kaye J, Ferris SH, Thomas RG, ... Thal LJ, et al. Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. Journal of Molecular Neuroscience : Mn. 20: 241-8. PMID 14501003 DOI: 10.1385/JMN:20:3:241  0.68
2003 Bondi MW, Houston WS, Salmon DP, Corey-Bloom J, Katzman R, Thal LJ, Delis DC. Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores. Journal of the International Neuropsychological Society : Jins. 9: 783-95. PMID 12901784 DOI: 10.1017/S1355617703950119  0.68
2003 Masliah E, Alford M, Adame A, Rockenstein E, Galasko D, Salmon D, Hansen LA, Thal LJ. Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. Neurology. 61: 206-11. PMID 12874400  0.68
2003 Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, Girones X, Henry TL, Matsubara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology. 61: 199-205. PMID 12874399  0.68
2003 Thal LJ. Therapeutics and mild cognitive impairment: current status and future directions. Alzheimer Disease and Associated Disorders. 17: S69-71. PMID 12813215  0.68
2003 Kennedy BP, Ziegler MG, Alford M, Hansen LA, Thal LJ, Masliah E. Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 110: 789-801. PMID 12811639 DOI: 10.1007/s00702-003-0828-6  0.68
2003 Tractenberg RE, Weiner MF, Patterson MB, Teri L, Thal LJ. Comorbidity of psychopathological domains in community-dwelling persons with Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 16: 94-9. PMID 12801159 DOI: 10.1177/0891988703016002006  0.68
2003 Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. Jama. 289: 2819-26. PMID 12783912 DOI: 10.1001/jama.289.21.2819  0.68
2003 Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ, Thal LJ, Corey-Bloom J. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 60: 1586-90. PMID 12771246  0.68
2003 Grundman M, Capparelli E, Kim HT, Morris JC, Farlow M, Rubin EH, Heidebrink J, Hake A, Ho G, Schultz AN, Schafer K, Houston W, Thomas R, Thal LJ. A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer's disease patients. Life Sciences. 73: 539-53. PMID 12770610 DOI: 10.1016/S0024-3205(03)00320-5  0.68
2003 Aisen PS, Schafer K, Grundman M, Thomas R, Thal LJ. NSAIDs and hypertension. Archives of Internal Medicine. 163: 1115; author reply 1. PMID 12742818 DOI: 10.1001/archinte.163.9.1115-a  0.68
2003 Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology. 18: 61-71. PMID 12598816 DOI: 10.1097/01.yic.0000058280.28578.79  0.68
2003 Thal LJ, Thomas RG, Mulnard R, Sano M, Grundman M, Schneider L. Estrogen levels do not correlate with improvement in cognition. Archives of Neurology. 60: 209-12. PMID 12580705 DOI: 10.1001/archneur.60.2.209  0.68
2003 Palmer BW, Bondi MW, Twamley EW, Thal L, Golshan S, Jeste DV. Are late-onset schizophrenia spectrum disorders neurodegenerative conditions? Annual rates of change on two dementia measures. The Journal of Neuropsychiatry and Clinical Neurosciences. 15: 45-52. PMID 12556570 DOI: 10.1176/appi.neuropsych.15.1.45  0.68
2003 Brandon EP, Lin W, D'Amour KA, Pizzo DP, Dominguez B, Sugiura Y, Thode S, Ko CP, Thal LJ, Gage FH, Lee KF. Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 539-49. PMID 12533614  0.68
2003 Aisen PS, Berg JD, Craft S, Peskind ER, Sano M, Teri L, Mulnard RA, Thomas RG, Thal LJ. Steroid-induced elevation of glucose in Alzheimer's disease: relationship to gender, apolipoprotein E genotype and cognition. Psychoneuroendocrinology. 28: 113-20. PMID 12445840 DOI: 10.1016/S0306-4530(02)00015-X  0.68
2002 Pizzo DP, Winkler J, Sidiqi I, Waite JJ, Thal LJ. Modulation of sensory inputs and ectopic presence of Schwann cells depend upon the route and duration of nerve growth factor administration. Experimental Neurology. 178: 91-103. PMID 12460611 DOI: 10.1006/exnr.2002.8010  0.68
2002 Pizzo DP, Thal LJ, Winkler J. Mnemonic deficits in animals depend upon the degree of cholinergic deficit and task complexity. Experimental Neurology. 177: 292-305. PMID 12429231 DOI: 10.1006/exnr.2002.7993  0.68
2002 Lange KL, Bondi MW, Salmon DP, Galasko D, Delis DC, Thomas RG, Thal LJ. Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype. Journal of the International Neuropsychological Society : Jins. 8: 943-55. PMID 12405546 DOI: 10.1017/S1355617702870096  0.68
2002 Ho GJ, Hansen LA, Alford MF, Foster K, Salmon DP, Galasko D, Thal LJ, Masliah E. Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport. 13: 1825-8. PMID 12395133  0.68
2002 Salmon DP, Thomas RG, Pay MM, Booth A, Hofstetter CR, Thal LJ, Katzman R. Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology. 59: 1022-8. PMID 12370456 DOI: 10.1016/0166-2236(86)90165-7  0.68
2002 Tiraboschi P, Hansen LA, Alford M, Merdes A, Masliah E, Thal LJ, Corey-Bloom J. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Archives of General Psychiatry. 59: 946-51. PMID 12365882  0.68
2002 Olichney JM, Morris SK, Ochoa C, Salmon DP, Thal LJ, Kutas M, Iragui VJ. Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 73: 377-84. PMID 12235303 DOI: 10.1136/jnnp.73.4.377  0.68
2002 Grundman M, Sencakova D, Jack CR, Petersen RC, Kim HT, Schultz A, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Thomas RG, Thal LJ. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. Journal of Molecular Neuroscience : Mn. 19: 23-7. PMID 12212787 DOI: 10.1007/s12031-002-0006-6  0.68
2002 Tractenberg RE, Gamst A, Thomas RG, Patterson M, Schneider LS, Thal LJ. Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 303-10. PMID 12154155 DOI: 10.1176/appi.neuropsych.14.3.303  0.68
2002 Pappolla MA, Smith MA, Bryant-Thomas T, Bazan N, Petanceska S, Perry G, Thal LJ, Sano M, Refolo LM. Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. Free Radical Biology & Medicine. 33: 173-81. PMID 12106813 DOI: 10.1016/S0891-5849(02)00841-9  0.68
2002 Rascovsky K, Salmon DP, Ho GJ, Galasko D, Peavy GM, Hansen LA, Thal LJ. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology. 58: 1801-8. PMID 12084880  0.68
2002 Weiner MF, Tractenberg RE, Sano M, Logsdon R, Teri L, Galasko D, Gamst A, Thomas R, Thal LJ. No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients. Journal of Geriatric Psychiatry and Neurology. 15: 95-8. PMID 12083600  0.64
2002 Tractenberg RE, Weiner MF, Patterson MB, Gamst A, Thal LJ. Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes. Journal of Geriatric Psychiatry and Neurology. 15: 110-7. PMID 12083593  0.68
2002 Grundman M, Farlow M, Peavy G, Kim HT, Capparelli E, Schultz AN, Salmon DP, Ferris SH, Mobs R, Thomas RG, Schafer K, Campbell K, Hake AM, Schoos B, Thal LJ, et al. A phase I study of AIT-082 in healthy elderly volunteers. Journal of Molecular Neuroscience : Mn. 18: 283-93. PMID 12059047 DOI: 10.1385/JMN:18:3:283  0.68
2002 Thal LJ. Effects of selegiline on fronto-temporal dementia: A neuropsychological evaluation International Journal of Geriatric Psychiatry. 17: 391-392. PMID 11994896 DOI: 10.1002/gps.602  0.68
2002 Tractenberg RE, Weiner MF, Thal LJ. Estimating the prevalence of agitation in community-dwelling persons with Alzheimer's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 11-8. PMID 11884649 DOI: 10.1176/appi.neuropsych.14.1.11  0.68
2002 Power AE, Thal LJ, McGaugh JL. Lesions of the nucleus basalis magnocellularis induced by 192 IgG-saporin block memory enhancement with posttraining norepinephrine in the basolateral amygdala. Proceedings of the National Academy of Sciences of the United States of America. 99: 2315-9. PMID 11830635 DOI: 10.1073/pnas.022627799  0.68
2002 Galasko D, Salmon DP, Craig UK, Thal LJ, Schellenberg G, Wiederholt W. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology. 58: 90-7. PMID 11781411  0.68
2002 Weiner MF, Tractenberg RE, Jin S, Gamst A, Thomas RG, Koss E, Thal LJ. Assessing Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory: scoring and clinical implications. Journal of Psychiatric Research. 36: 19-25. PMID 11755457 DOI: 10.1016/S0022-3956(01)00047-4  0.68
2001 Sabbagh MN, Reid RT, Hansen LA, Alford M, Thal LJ. Correlation of nicotinic receptor binding with clinical and neuropathological changes in Alzheimer's disease and dementia with Lewy bodies. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 1149-57. PMID 11725817 DOI: 10.1007/s007020170004  0.68
2001 Reid RT, Sabbagh MN, Thal LJ. Does apolipoprotein E (Apo-E) genotype influence nicotinic receptor binding in Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 1043-50. PMID 11716140 DOI: 10.1007/s007020170023  0.68
2001 Frisoni GB, Geroldi C, Thal LJ. Cerebrovascular disease affects noncognitive symptoms in Alzheimer disease Archives of Neurology. 58: 1939-1940. PMID 11709007  0.68
2001 Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 56: 1154-66. PMID 11342679  0.68
2001 Jellinger KA. Small concomitant cerebrovascular lesions are not important for cognitive decline in severe Alzheimer disease. Archives of Neurology. 58: 520-1. PMID 11255466  0.68
2001 Barrett AM. A 1-year controlled trial of acetyl-L-carnitine in early-onset AD. Neurology. 56: 425. PMID 11171924  0.68
2000 Sabbagh MN, Galasko D, Koo E, Thal LJ. Amyloid-beta and treatment opportunities for Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 2: 231-59. PMID 12214087  0.68
2000 Paulsen JS, Ready RE, Stout JC, Salmon DP, Thal LJ, Grant I, Jeste DV. Neurobehaviors and psychotic symptoms in Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 6: 815-20. PMID 11105471 DOI: 10.1017/S1355617700677081  0.68
2000 Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J. The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. Neurology. 55: 1278-83. PMID 11087768  0.68
2000 Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE, Foster NL, Schneider LS, Sano M, Whitehouse P, Tariot P, Mellow AM, Auchus AP, Grundman M, Thomas RG, ... ... Thal LJ, et al. Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology. 55: 1271-8. PMID 11087767  0.68
2000 Tractenberg RE, Jin S, Patterson M, Schneider LS, Gamst A, Thomas RG, Thal LJ. Qualifying change: a method for defining clinically meaningful outcomes of change score computation. Journal of the American Geriatrics Society. 48: 1478-82. PMID 11083327  0.68
2000 Tractenberg RE, Patterson M, Weiner MF, Teri L, Grundman M, Thomas RG, Thal LJ. Prevalence of symptoms on the CERAD behavior rating scale for dementia in normal elderly subjects and Alzheimer's disease patients. The Journal of Neuropsychiatry and Clinical Neurosciences. 12: 472-9. PMID 11083164 DOI: 10.1176/appi.neuropsych.12.4.472  0.68
2000 Grundman M, Thal LJ. Treatment of Alzheimer's disease: rationale and strategies. Neurologic Clinics. 18: 807-28. PMID 11072262 DOI: 10.1016/S0733-8619(05)70227-9  0.68
2000 Lee JH, Olichney JM, Hansen LA, Hofstetter CR, Thal LJ. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Archives of Neurology. 57: 1474-9. PMID 11030800  0.68
2000 Rei RT, Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thal LJ. Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease. Neurobiology of Aging. 21: 741-6. PMID 11016544 DOI: 10.1016/S0197-4580(00)00168-8  0.68
2000 Thal LJ, Calvani M, Amato A, Carta A. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD. Neurology. 55: 805-10. PMID 10994000  0.68
2000 Thal LJ. Trials to slow progression and prevent disease onset. Journal of Neural Transmission. Supplementum. 59: 243-9. PMID 10961435  0.68
2000 Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal LJ. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Archives of Neurology. 57: 869-74. PMID 10867785  0.68
2000 Thal LJ. Anti-inflammatory drugs and Alzheimer's disease. Neurobiology of Aging. 21: 449-50; discussion 4. PMID 10858593 DOI: 10.1016/S0197-4580(00)00139-1  0.68
2000 Bayley PJ, Salmon DP, Bondi MW, Bui BK, Olichney J, Delis DC, Thomas RG, Thal LJ. Comparison of the serial position effect in very mild Alzheimer's disease, mild Alzheimer's disease, and amnesia associated with electroconvulsive therapy. Journal of the International Neuropsychological Society : Jins. 6: 290-8. PMID 10824501 DOI: 10.1017/S1355617700633040  0.68
2000 Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology. 54: 1965-71. PMID 10822438  0.68
2000 Olichney JM, Hansen LA, Lee JH, Hofstetter CR, Katzman R, Thal LJ. Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer's disease. Annals of the New York Academy of Sciences. 903: 138-43. PMID 10818499  0.68
2000 Pappas BA, Bayley PJ, Bui BK, Hansen LA, Thal LJ. Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients. Neurobiology of Aging. 21: 11-7. PMID 10794843 DOI: 10.1016/S0197-4580(00)00090-7  0.68
2000 Weiner MF, Tractenberg R, Teri L, Logsdon R, Thomas RG, Gamst A, Thal LJ. Quantifying behavioral disturbance in Alzheimer's disease patients. Journal of Psychiatric Research. 34: 163-7. PMID 10758259 DOI: 10.1016/S0022-3956(99)00042-4  0.68
2000 Hohl U, Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. Diagnostic accuracy of dementia with Lewy bodies. Archives of Neurology. 57: 347-51. PMID 10714660  0.68
2000 Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 2218-28. PMID 10704497  0.68
2000 Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. Jama. 283: 1007-15. PMID 10697060  0.68
2000 Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, Weiner MF, Farlow MR, Sano M, Grundman M, Thal LJ. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology. 54: 588-93. PMID 10680787  0.68
2000 Thal LJ, Forrest M, Loft H, Mengel H. Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer's disease. Lu25-109 Study Group. Neurology. 54: 421-6. PMID 10668706  0.68
2000 Tiraboschi P, Hansen LA, Alford M, Sabbagh MN, Schoos B, Masliah E, Thal LJ, Corey-Bloom J. Cholinergic dysfunction in diseases with Lewy bodies. Neurology. 54: 407-11. PMID 10668703  0.68
2000 Corey-Bloom J, Tiraboschi P, Hansen LA, Alford M, Schoos B, Sabbagh MN, Masliah E, Thal LJ. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease. Neurology. 54: 403-6. PMID 10668702  0.68
2000 Winkler J, Ramirez GA, Thal LJ, Waite JJ. Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 834-44. PMID 10632613  0.68
2000 Licastro F, Masliah E, Pedrini S, Thal LJ. Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype. Dementia and Geriatric Cognitive Disorders. 11: 25-8. PMID 10629358  0.68
2000 Sabbagh MN, Galasko D, Koo E, Thal LJ. Amyloid-β and treatment opportunities for Alzheimer's disease Journal of Alzheimer's Disease. 2: 231-259.  0.68
1999 Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thomas R, Masliah E, Thal LJ. Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease. Archives of Neurology. 56: 1458-61. PMID 10593300  0.64
1999 Logsdon RG, Teri L, Weiner MF, Gibbons LE, Raskind M, Peskind E, Grundman M, Koss E, Thomas RG, Thal LJ. Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative Study. Journal of the American Geriatrics Society. 47: 1354-8. PMID 10573447  0.68
1999 Pizzo DP, Waite JJ, Thal LJ, Winkler J. Intraparenchymal infusions of 192 IgG-saporin: development of a method for selective and discrete lesioning of cholinergic basal forebrain nuclei. Journal of Neuroscience Methods. 91: 9-19. PMID 10522820 DOI: 10.1016/S0165-0270(99)00057-6  0.68
1999 Kawas CH, Clark CM, Farlow MR, Knopman DS, Marson D, Morris JC, Thal LJ, Whitehouse PJ. Clinical trials in Alzheimer disease: debate on the use of placebo controls. Alzheimer Disease and Associated Disorders. 13: 124-9. PMID 10485569  0.68
1999 Bondi MW, Salmon DP, Galasko D, Thomas RG, Thal LJ. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology and Aging. 14: 295-303. PMID 10403716 DOI: 10.1037/0882-7974.14.2.295  0.68
1999 Hohl U, Grundman M, Salmon DP, Thomas RG, Thal LJ. Mini-Mental State Examination and Mattis Dementia Rating Scale performance differs in Hispanic and non-Hispanic Alzheimer's disease patients. Journal of the International Neuropsychological Society : Jins. 5: 301-7. PMID 10349293 DOI: 10.1017/S1355617799544019  0.68
1999 Thal LJ, Ferguson JM, Mintzer J, Raskin A, Targum SD. A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease. Neurology. 52: 1146-52. PMID 10214735  0.68
1999 Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M. Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative Study. Neurology. 52: 714-8. PMID 10078715  0.68
1999 Imbimbo BP, Martelli P, Troetel WM, Lucchelli F, Lucca U, Thal LJ. Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease. Neurology. 52: 700-8. PMID 10078713  0.68
1998 Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD. Retraction. Proceedings of the National Academy of Sciences of the United States of America. 95: 12069. PMID 16578857  0.68
1998 Imbimbo BP, Lucca U, Lucchelli F, Alberoni M, Thal LJ. A 25-week placebo-controlled study of eptastigmine in patients with Alzheimer disease. Alzheimer Disease and Associated Disorders. 12: 313-22. PMID 9876959  0.68
1998 Weiner MF, Koss E, Patterson M, Jin S, Teri L, Thomas R, Thal LJ, Whitehouse P. A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease. Journal of Psychiatric Research. 32: 347-51. PMID 9844950 DOI: 10.1016/S0022-3956(98)00027-2  0.68
1998 Sabbagh MN, Reid RT, Corey-Bloom J, Rao TS, Hansen LA, Alford M, Masliah E, Adem A, Lloyd GK, Thal LJ. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 709-17. PMID 9826113 DOI: 10.1007/s007020050090  0.68
1998 Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology. 51: 351-7. PMID 9710002  0.68
1998 Grundman M, Corey-Bloom J, Thal LJ. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs. Journal of Neural Transmission. Supplementum. 53: 255-75. PMID 9700663  0.68
1998 Conrad C, Amano N, Andreadis A, Xia Y, Namekataf K, Oyama F, Ikeda K, Wakabayashi K, Takahashi H, Thal LJ, Katzman R, Shackelford DA, Matsushita M, Masliah E, Sawa A. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy. Neuroscience Letters. 250: 135-7. PMID 9697937 DOI: 10.1016/S0304-3940(98)00417-0  0.68
1998 Winkler J, Thal LJ, Gage FH, Fisher LJ. Cholinergic strategies for Alzheimer's disease. Journal of Molecular Medicine (Berlin, Germany). 76: 555-67. PMID 9694432 DOI: 10.1007/s001090050250  0.68
1998 Connor DJ, Salmon DP, Sandy TJ, Galasko D, Hansen LA, Thal LJ. Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. Archives of Neurology. 55: 994-1000. PMID 9678318 DOI: 10.1001/archneur.55.7.994  0.68
1998 Hsu LJ, Mallory M, Xia Y, Veinbergs I, Hashimoto M, Yoshimoto M, Thal LJ, Saitoh T, Masliah E. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. Journal of Neurochemistry. 71: 338-44. PMID 9648883  0.68
1998 Tanaka S, Chen X, Xia Y, Kang DE, Matoh N, Sundsmo M, Thomas RG, Katzman R, Thal LJ, Trojanowski JQ, Saitoh T, Ueda K, Masliah E. Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease. Neurology. 50: 1556-62. PMID 9633694  0.68
1998 Winkler J, Power AE, Ramirez GA, Thal LJ. Short-term and complete reversal of NGF effects in rats with lesions of the nucleus basalis magnocellularis. Brain Research. 788: 1-12. PMID 9554932 DOI: 10.1016/S0006-8993(97)01508-4  0.68
1998 Ellis RJ, Jan K, Kawas C, Koller WC, Lyons KE, Jeste DV, Hansen LA, Thal LJ. Diagnostic validity of the dementia questionnaire for Alzheimer disease. Archives of Neurology. 55: 360-5. PMID 9520010 DOI: 10.1001/archneur.55.3.360  0.68
1998 Robledo P, Somes C, Winkler J, Thal LJ, Ehlers CL. Long latency event-related potentials in rats: Effects of nucleus basalis magnocellularis lesions International Journal of Neuroscience. 96: 23-44.  0.68
1997 Bodick N, Forette F, Hadler D, Harvey RJ, Leber P, McKeith IG, Riekkinen PJ, Rossor MN, Scheltens P, Shimohama S, Spiegel R, Tanaka S, Thal LJ, Urata Y, Whitehouse P, et al. Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group. Alzheimer Disease and Associated Disorders. 11: 50-3. PMID 9305517  0.68
1997 Thal LJ, Carta A, Doody R, Leber P, Mohs R, Schneider L, Shimohama S, Silber C. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Disease and Associated Disorders. 11: 46-9. PMID 9305516  0.68
1997 Thal LJ, Thomas RG, Sano M. Tacrine and nursing home placement. Neurology. 49: 897-9. PMID 9305370  0.68
1997 Gold M, Thal LJ. Physostigmine and Alzheimer's disease [4] (multiple letters) Neurology. 49: 642-643. PMID 9270628  0.68
1997 Pincus MM, Kilander L, Ohrvall M, Sano M, Thomas RG, Thal LJ. Alpha-tocopherol and Alzheimer's disease [3] (multiple letters) New England Journal of Medicine. 337: 572-573. PMID 9265106 DOI: 10.1056/NEJM199708213370814  0.68
1997 Mackell JA, Ferris SH, Mohs R, Schneider L, Galasko D, Whitehouse P, Schmitt F, Sano M, Thal LJ. Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S65-9. PMID 9236955  0.68
1997 Sano M, Mackell JA, Ponton M, Ferreira P, Wilson J, Pawluczyk S, Pfeiffer E, Thomas RG, Jin S, Schafer K, Schittini M, Grundman M, Ferris SH, Thal LJ. The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S57-64. PMID 9236954  0.68
1997 Schmitt FA, Ashford W, Ernesto C, Saxton J, Schneider LS, Clark CM, Ferris SH, Mackell JA, Schafer K, Thal LJ. The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S51-6. PMID 9236953  0.68
1997 Koss E, Weiner M, Ernesto C, Cohen-Mansfield J, Ferris SH, Grundman M, Schafer K, Sano M, Thal LJ, Thomas R, Whitehouse PJ. Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S45-50. PMID 9236952  0.6
1997 Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S13-21. PMID 9236948  0.68
1997 Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S1-12. PMID 9236947  0.68
1997 Crook R, Ellis R, Shanks M, Thal LJ, Perez-Tur J, Baker M, Hutton M, Haltia T, Hardy J, Galasko D. Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation. Annals of Neurology. 42: 124-8. PMID 9225696 DOI: 10.1002/ana.410420121  0.68
1997 Olichney JM, Sabbagh MN, Hofstetter CR, Galasko D, Grundman M, Katzman R, Thal LJ. The impact of apolipoprotein E4 on cause of death in Alzheimer's disease. Neurology. 49: 76-81. PMID 9222173  0.68
1997 Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology. 49: 56-61. PMID 9222170  0.68
1997 Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 5820-9. PMID 9221780  0.68
1997 Morris JC, Ernesto C, Schafer K, Coats M, Leon S, Sano M, Thal LJ, Woodbury P. Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology. 48: 1508-10. PMID 9191756  0.68
1997 Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 94: 4526-31. PMID 9114023 DOI: 10.1073/pnas.94.9.4526  0.68
1997 Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. The New England Journal of Medicine. 336: 1216-22. PMID 9110909 DOI: 10.1056/NEJM199704243361704  0.68
1997 Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Archives of Neurology. 54: 416-24. PMID 9109743  0.68
1997 Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Annals of Neurology. 41: 277-81. PMID 9029080 DOI: 10.1002/ana.410410222  0.68
1997 Corey-Bloom J, Sabbagh MN, Bondi MW, Hansen L, Alford MF, Masliah E, Thal LJ. Hippocampal sclerosis contributes to dementia in the elderly. Neurology. 48: 154-60. PMID 9008511  0.68
1997 Winkler J, Ramirez GA, Kuhn HG, Peterson DA, Day-Lollini PA, Stewart GR, Tuszynski MH, Gage FH, Thal LJ. Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor. Annals of Neurology. 41: 82-93. PMID 9005869 DOI: 10.1002/ana.410410114  0.68
1997 Thal LJ. Development of the Alzheimer's disease cooperative study International Journal of Geriatric Psychopharmacology. 1: 6-9.  0.68
1996 Mehta P, Gulevich SJ, Thal LJ, Jin H, Olichney JM, McCutchan JA, Heaton RK, Kirson D, Kaplanski G, Nelson J, Atkinson JH, Wallace MR, Grant I, Group H. Neurological Symptoms, Not Signs,
Are Common in Early HIV Infection. Journal of Neuro-Aids. 1: 67-85. PMID 16873165 DOI: 10.1300/J128v01n02_05 
0.36
1996 Thal LJ. Neurotrophic factors. Progress in Brain Research. 109: 327-30. PMID 9009720  0.68
1996 Thal LJ. Cholinomimetic treatment of Alzheimer's disease. Progress in Brain Research. 109: 299-309. PMID 9009718  0.68
1996 Thal LJ, Schwartz G, Sano M, Weiner M, Knopman D, Harrell L, Bodenheimer S, Rossor M, Philpot M, Schor J, Goldberg A. A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. Neurology. 47: 1389-95. PMID 8960716  0.68
1996 Thal LJ. Potential prevention strategies for Alzheimer disease. Alzheimer Disease and Associated Disorders. 10: 6-8. PMID 8876780  0.68
1996 Sano M, Ernesto C, Klauber MR, Schafer K, Woodbury P, Thomas R, Grundman M, Growdon J, Thal LJ. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 10: 132-40. PMID 8876776  0.68
1996 Salmon DP, Galasko D, Hansen LA, Masliah E, Butters N, Thal LJ, Katzman R. Neuropsychological deficits associated with diffuse Lewy body disease. Brain and Cognition. 31: 148-65. PMID 8811990 DOI: 10.1006/brcg.1996.0039  0.68
1996 Peskind ER, Raskind MA, Wingerson D, Pascualy M, Thal LJ, Dobie DJ, Wilkinson CW. Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender. Biological Psychiatry. 40: 61-8. PMID 8780856 DOI: 10.1016/0006-3223(95)00318-5  0.68
1996 Xia Y, Rohan de Silva HA, Rosi BL, Yamaoka LH, Rimmler JB, Pericak-Vance MA, Roses AD, Chen X, Masliah E, DeTeresa R, Iwai A, Sundsmo M, Thomas RG, Hofstetter CR, Gregory E, ... ... Thal LJ, et al. Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism. Annals of Neurology. 40: 207-15. PMID 8773602 DOI: 10.1002/ana.410400212  0.64
1996 Ellis RJ, Caligiuri M, Galasko D, Thal LJ. Extrapyramidal motor signs in clinically diagnosed Alzheimer disease. Alzheimer Disease and Associated Disorders. 10: 103-14. PMID 8727172 DOI: 10.1097/00002093-199601020-00008  0.68
1996 Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology. 47: 190-6. PMID 8710076  0.68
1996 Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology. 46: 1592-6. PMID 8649554  0.68
1996 Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology. 46: 1585-91. PMID 8649553  0.68
1996 Waite JJ, Thal LJ. Lesions of the cholinergic nuclei in the rat basal forebrain: excitotoxins vs. an immunotoxin. Life Sciences. 58: 1947-53. PMID 8637423 DOI: 10.1016/0024-3205(96)00184-1  0.68
1996 Mehta P, Gulevich SJ, Thal LJ, Jin H, Olichney JM, McCutchan JA, Heaton RK, Kirson D, Kaplanski G, Nelson J, Atkinson JH, Wallace MR, Grant I. Neurological symptoms, not signs, are common in early HIV infection Journal of Neuro-Aids. 1: 67-85.  0.68
1995 Bondi MW, Salmon DP, Monsch AU, Galasko D, Butters N, Klauber MR, Thal LJ, Saitoh T. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology. 45: 2203-6. PMID 8848194  0.68
1995 Katzman R, Galasko D, Saitoh T, Thal LJ, Hansen L. Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain and Cognition. 28: 259-65. PMID 8546853 DOI: 10.1006/brcg.1995.1256  0.68
1995 Peskind ER, Raskind MA, Wingerson D, Pascualy M, Thal LJ, Dobie DJ, Veith RC, Dorsa DM, Murray S, Sikkema C. Enhanced hypothalamic-pituitary-adrenocortical axis responses to physostigmine in normal aging. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 50: M114-20. PMID 7874590  0.68
1995 Olichney JM, Galasko D, Corey-Bloom J, Thal LJ. The spectrum of diseases with diffuse Lewy bodies. Advances in Neurology. 65: 159-70. PMID 7872137  0.68
1995 Corey-Bloom J, Thal LJ, Galasko D, Folstein M, Drachman D, Raskind M, Lanska DJ. Diagnosis and evaluation of dementia. Neurology. 45: 211-8. PMID 7854514  0.64
1995 Saitoh T, Xia Y, Chen X, Masliah E, Galasko D, Shults C, Thal LJ, Hansen LA, Katzman R. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Annals of Neurology. 37: 110-2. PMID 7818242 DOI: 10.1002/ana.410370120  0.68
1995 Waite JJ, Chen AD, Wardlow ML, Wiley RG, Lappi DA, Thal LJ. 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells. Neuroscience. 65: 463-76. PMID 7777161 DOI: 10.1016/0306-4522(94)00479-O  0.68
1995 Winkler J, Suhr ST, Gage FH, Thal LJ, Fisher LJ. Essential role of neocortical acetylcholine in spatial memory. Nature. 375: 484-7. PMID 7777056 DOI: 10.1038/375484a0  0.68
1995 Monsch AU, Bondi MW, Salmon DP, Butters N, Thal LJ, Hansen LA, Wiederholt WC, Cahn DA, Klauber MR. Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Archives of Neurology. 52: 899-904. PMID 7661728 DOI: 10.1001/archneur.1995.00540330081018  0.68
1995 Olichney JM, Hofstetter CR, Galasko D, Thal LJ, Katzman R. Death certificate reporting of dementia and mortality in an Alzheimer's disease research center cohort. Journal of the American Geriatrics Society. 43: 890-3. PMID 7636097  0.68
1995 Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Archives of Neurology. 52: 702-8. PMID 7619027 DOI: 10.1001/archneur.1995.00540310076019  0.68
1995 Winkler J, Thal LJ. Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA. Experimental Neurology. 136: 234-50. PMID 7498413 DOI: 10.1006/exnr.1995.1100  0.64
1995 Davis KL, Yang RK, Davidson M, Mohs RC, Ryan TM, Schmeidler J, Knott PJ, Thal LJ, Gamzu ER. Alzheimer's disease: Tacrine and tacrine metabolite concentrations in plasma and cognitive change Drug Development Research. 34: 55-65. DOI: 10.1002/ddr.430340109  0.68
1994 Dekker AJ, Fagan AM, Gage FH, Thal LJ. Effects of brain-derived neurotrophic factor and nerve growth factor on remaining neurons in the lesioned nucleus basalis magnocellularis. Brain Research. 639: 149-55. PMID 8180830 DOI: 10.1016/0006-8993(94)91775-2  0.68
1994 Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Lessin P, Thal LJ. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Archives of Neurology. 51: 888-95. PMID 8080388 DOI: 10.1001/archneur.1994.00540210060013  0.68
1994 Dekker AJ, Winkler J, Ray J, Thal LJ, Gage FH. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience. 60: 299-309. PMID 8072685 DOI: 10.1016/0306-4522(94)90244-5  0.68
1994 Waite JJ, Wardlow ML, Chen AC, Lappi DA, Wiley RG, Thal LJ. Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192 IgG-saporin. Neuroscience Letters. 169: 154-8. PMID 8047273 DOI: 10.1016/0304-3940(94)90379-4  0.68
1994 Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology. 44: 1950-1. PMID 7936253  0.64
1994 Winkler J, Connor DJ, Frautschy SA, Behl C, Waite JJ, Cole GM, Thal LJ. Lack of long-term effects after beta-amyloid protein injections in rat brain. Neurobiology of Aging. 15: 601-7. PMID 7824051  0.64
1993 Dekker AJ, Thal LJ. Nerve growth factor increases cortical choline acetyltransferase-positive fiber staining without affecting cortical cholinergic neurons. Brain Research. 601: 329-32. PMID 8431782 DOI: 10.1016/0006-8993(93)91731-7  0.68
1993 Corey-Bloom J, Galasko D, Hofstetter CR, Jackson JE, Thal LJ. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. Journal of the American Geriatrics Society. 41: 31-7. PMID 8418119  0.68
1993 Galasko D, Abramson I, Corey-Bloom J, Thal LJ. Repeated exposure to the Mini-Mental State Examination and the Information-Memory-Concentration Test results in a practice effect in Alzheimer's disease. Neurology. 43: 1559-63. PMID 8351011  0.68
1993 Gulevich SJ, McCutchan JA, Thal LJ, Kirson D, Durand D, Wallace M, Mehta P, Heyes MP, Grant I. Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndromes. 6: 1002-7. PMID 8101873  0.68
1993 Connor DJ, Langdon DJ, Langlais PJ, Thal LJ. Effects of NBm lesions on T-maze performance and thalamic biochemistry. Neurobiology of Aging. 14: 535-7. PMID 7905188  0.48
1993 Dekker AJ, Thal LJ. Independent effects of cholinergic and serotonergic lesions on acetylcholine and serotonin release in the neocortex of the rat. Neurochemical Research. 18: 277-83. PMID 7683117 DOI: 10.1007/BF00969083  0.68
1993 Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ. Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature. 361: 260-3. PMID 7678698 DOI: 10.1038/361260a0  0.68
1992 Jeste DV, Wragg RE, Salmon DP, Harris MJ, Thal LJ. Cognitive deficits of patients with Alzheimer's disease with and without delusions. The American Journal of Psychiatry. 149: 184-9. PMID 1734737  0.68
1992 Thal LJ, Gilbertson E, Armstrong DM, Gage FH. Development of the basal forebrain cholinergic system: phenotype expression prior to target innervation. Neurobiology of Aging. 13: 67-72. PMID 1542384 DOI: 10.1016/0197-4580(92)90011-L  0.68
1992 Dekker AJ, Thal LJ. Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: dose requirements. Brain Research. 584: 55-63. PMID 1515953 DOI: 10.1016/0006-8993(92)90877-C  0.68
1992 Monsch AU, Bondi MW, Butters N, Salmon DP, Katzman R, Thal LJ. Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Archives of Neurology. 49: 1253-8. PMID 1449404 DOI: 10.1001/archneur.1992.00530360051017  0.68
1992 Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. The New England Journal of Medicine. 327: 1253-9. PMID 1406817 DOI: 10.1056/NEJM199210293271801  0.68
1992 Dekker AJ, Gage FH, Thal LJ. Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems. Neuroscience. 48: 111-9. PMID 1374860 DOI: 10.1016/0306-4522(92)90342-Y  0.68
1992 Gulevich SJ, Kalmijn JA, Thal LJ, Iragui-Madoz V, McCutchan JA, Kennedy C, Grant I. Sensory testing in human immunodeficiency virus type 1-infected men. HIV Neurobehavioral Research Center Group. Archives of Neurology. 49: 1281-4. PMID 1360202 DOI: 10.1001/archneur.1992.00530360083022  0.68
1992 Connor DJ, Thal LJ, Mandel RJ, Langlais PJ, Masliah E. Independent effects of age and nucleus basalis magnocellularis lesion: maze learning, cortical neurochemistry, and morphometry. Behavioral Neuroscience. 106: 776-88. PMID 1280146 DOI: 10.1037/0735-7044.106.5.776  0.68
1991 Atack JR, Litvan I, Thal LJ, May C, Rapoport SI, Chase TN. Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine. Journal of Neurology, Neurosurgery, and Psychiatry. 54: 832-5. PMID 1955905 DOI: 10.1136/jnnp.54.9.832  0.68
1991 Dekker AJ, Connor DJ, Thal LJ. The role of cholinergic projections from the nucleus basalis in memory. Neuroscience and Biobehavioral Reviews. 15: 299-317. PMID 1852317  0.6
1991 Galasko D, Corey-Bloom J, Thal LJ. Monitoring progression in Alzheimer's disease. Journal of the American Geriatrics Society. 39: 932-41. PMID 1842209  0.68
1991 Dekker AJ, Langdon DJ, Gage FH, Thal LJ. NGF increases cortical acetylcholine release in rats with lesions of the nucleus basalis. Neuroreport. 2: 577-80. PMID 1756238  0.68
1990 Gamzu ER, Thal LJ, Davis KL. Therapeutic trials using tacrine and other cholinesterase inhibitors. Advances in Neurology. 51: 241-5. PMID 2403716  0.68
1990 Salmon DP, Thal LJ, Butters N, Heindel WC. Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology. 40: 1225-30. PMID 2381530  0.68
1990 Kwo-On-Yuen PF, Mandel R, Chen AD, Thal LJ. Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats. Experimental Neurology. 108: 221-8. PMID 2351210  0.36
1990 Galasko D, Kwo-on-Yuen PF, Klauber MR, Thal LJ. Neurological findings in Alzheimer's disease and normal aging. Archives of Neurology. 47: 625-7. PMID 2346387  0.68
1990 Thal LJ, Mandel RJ, Terry RD, Buzsaki G, Gage FH. Nucleus basalis lesions fail to induce senile plaques in the rat. Experimental Neurology. 108: 88-90. PMID 2318291 DOI: 10.1016/0014-4886(90)90013-I  0.68
1990 Galasko D, Klauber MR, Hofstetter CR, Salmon DP, Lasker B, Thal LJ. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. Archives of Neurology. 47: 49-52. PMID 2294894 DOI: 10.1001/archneur.1990.00530010061020  0.68
1989 Mandel RJ, Gage FH, Thal LJ. Enhanced detection of nucleus basalis magnocellularis lesion-induced spatial learning deficit in rats by modification of training regimen. Behavioural Brain Research. 31: 221-9. PMID 2914073 DOI: 10.1016/0166-4328(89)90004-1  0.68
1989 Thal LJ, Lasker B, Sharpless NS, Bobotas G, Schor JM, Nigalye A. Plasma physostigmine concentrations after controlled-release oral administration. Archives of Neurology. 46: 13. PMID 2910256  0.4
1989 Mandel RJ, Chen AD, Connor DJ, Thal LJ. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers. The Journal of Pharmacology and Experimental Therapeutics. 251: 612-9. PMID 2810114  0.68
1989 Masur DM, Fuld PA, Blau AD, Thal LJ, Levin HS, Aronson MK. Distinguishing normal and demented elderly with the selective reminding test. Journal of Clinical and Experimental Neuropsychology. 11: 615-30. PMID 2808653 DOI: 10.1080/01688638908400920  0.68
1989 Mandel RJ, Gage FH, Thal LJ. Spatial learning in rats: correlation with cortical choline acetyltransferase and improvement with NGF following NBM damage. Experimental Neurology. 104: 208-17. PMID 2721623 DOI: 10.1016/0014-4886(89)90031-9  0.68
1989 Thal LJ, Salmon DP, Lasker B, Bower D, Klauber MR. The safety and lack of efficacy of vinpocetine in Alzheimer's disease. Journal of the American Geriatrics Society. 37: 515-20. PMID 2715559  0.48
1989 Thal LJ, Masur DM, Blau AD, Fuld PA, Klauber MR. Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease. Journal of the American Geriatrics Society. 37: 42-8. PMID 2642499  0.68
1989 Salmon DP, Kwo-on-Yuen PF, Heindel WC, Butters N, Thal LJ. Differentiation of Alzheimer's disease and Huntington's disease with the Dementia Rating Scale. Archives of Neurology. 46: 1204-8. PMID 2530966 DOI: 10.1001/archneur.1989.00520470060028  0.68
1988 Thal LJ, Grundman M, Klauber MR. Dementia: characteristics of a referral population and factors associated with progression. Neurology. 38: 1083-90. PMID 3386827  0.32
1988 Katzman R, Brown T, Thal LJ, Fuld PA, Aronson M, Butters N, Klauber MR, Wiederholt W, Pay M, Xiong RB. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Annals of Neurology. 24: 384-9. PMID 3228273 DOI: 10.1002/ana.410240306  0.68
1988 Thal LJ, Dokla CP, Armstrong DM. Nucleus basalis magnocellularis lesions: lack of biochemical and immunocytochemical recovery and effect of cholinesterase inhibitors on passive avoidance. Behavioral Neuroscience. 102: 852-60. PMID 3214535 DOI: 10.1037/0735-7044.102.6.852  0.68
1988 Buzsáki G, Bickford RG, Armstrong DM, Ponomareff G, Chen KS, Ruiz R, Thal LJ, Gage FH. Electric activity in the neocortex of freely moving young and aged rats. Neuroscience. 26: 735-44. PMID 3200427 DOI: 10.1016/0306-4522(88)90095-4  0.68
1988 Buzsaki G, Bickford RG, Ponomareff G, Thal LJ, Mandel R, Gage FH. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 4007-26. PMID 3183710  0.68
1988 Mandel RJ, Thal LJ. Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats. Psychopharmacology. 96: 421-5. PMID 3146779 DOI: 10.1007/BF00216074  0.68
1988 Dickson DW, Horoupian DS, Thal LJ, Lantos G. Gliomatosis cerebri presenting with hydrocephalus and dementia. Ajnr. American Journal of Neuroradiology. 9: 200-2. PMID 3124573  0.68
1988 Wolfson LI, Sharpless NS, Thal LJ. Diminished levels of ventricular fluid norepinephrine metabolite and somatostatin in childhood-onset dystonia. Advances in Neurology. 50: 177-81. PMID 2456674  0.4
1987 Wiley CA, VanPatten PD, Carpenter PM, Powell HC, Thal LJ. Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2. Neurology. 37: 1791-4. PMID 3670617  0.68
1986 Thal LJ, Grundman M, Golden R. Alzheimer's disease: a correlational analysis of the Blessed Information-Memory-Concentration Test and the Mini-Mental State Exam. Neurology. 36: 262-4. PMID 3945395  0.32
1986 Thal LJ, Masur DM, Sharpless NS, Fuld PA, Davies P. Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 627-36. PMID 3797688 DOI: 10.1016/0278-5846(86)90032-1  0.68
1986 Dickson DW, Horoupian DS, Thal LJ, Davies P, Walkley S, Terry RD. Klüver-Bucy syndrome and amyotrophic lateral sclerosis: a case report with biochemistry, morphometrics, and Golgi study. Neurology. 36: 1323-9. PMID 3762937  0.68
1986 Wolfson LI, Thal LJ, Brown LL. Serotonin models of myoclonus in the guinea pig and rat. Advances in Neurology. 43: 519-27. PMID 3484858  0.68
1986 Thal LJ, Laing K, Horowitz SG, Makman MH. Dopamine stimulates rat cortical somatostatin release. Brain Research. 372: 205-9. PMID 2871899  0.6
1985 Thal LJ, Sharpless NS, Rosenbaum D, Davies P, Amin IM, Waltz JM. Ventricular fluid somatostatin concentration decreases in childhood-onset dystonia. Neurology. 35: 1742-6. PMID 2866469  0.4
1985 Sharpless NS, Thal LJ. Plasma physostigmine concentrations after oral administration. Lancet (London, England). 1: 1397-8. PMID 2861349  0.4
1984 Sharpless NS, Thal LJ, Perlow MJ, Tabaddor K, Waltz JM, Shapiro KN, Amin IM, Engel J, Crandall PH. Vasoactive intestinal peptide in cerebrospinal fluid. Peptides. 5: 429-33. PMID 6473166  0.4
1983 Schonfeld AR, Thal LJ, Horowitz SG, Katzman R. Heart conditioned medium elicits post-lesion muscarinic receptor recovery in vivo. Brain Research. 266: 271-8. PMID 6871663 DOI: 10.1016/0006-8993(83)90658-3  0.68
1983 Thal LJ, Sharpless NS. Narcolepsy and hypersomnia. Neurology. 33: 1394-5. PMID 6684244  0.4
1983 Wolfson LI, Sharpless NS, Thal LJ, Waltz JM, Shapiro K. Decreased ventricular fluid norepinephrine metabolite in childhood-onset dystonia. Neurology. 33: 369-72. PMID 6681883  0.4
1983 Thal LJ, Fuld PA, Masur DM, Sharpless NS, Davies P. Oral physostigmine and lecithin improve memory in Alzheimer's disease. Psychopharmacology Bulletin. 19: 454-6. PMID 6635124  0.68
1983 Thal LJ, Fuld PA, Masur DM, Sharpless NS. Oral physostigmine and lecithin improve memory in Alzheimer disease. Annals of Neurology. 13: 491-6. PMID 6347034 DOI: 10.1002/ana.410130504  0.68
1983 Thal LJ, Sharpless NS, Hirschhorn ID, Horowitz SG, Makman MH. Striatal met-enkephalin concentration increases following nigrostriatal denervation. Biochemical Pharmacology. 32: 3297-301. PMID 6140008  0.6
1981 Thal LJ, Rosen W, Sharpless NS, Crystal H. Choline chloride in Alzheimer disease. Annals of Neurology. 10: 580. PMID 7325608 DOI: 10.1002/ana.410100617  0.4
1981 Thal LJ, Rosen W, Sharpless NS, Crystal H. Choline chloride fails to improve cognition of Alzheimer's disease. Neurobiology of Aging. 2: 205-8. PMID 7312098  0.4
1981 Schonfeld AR, Thal LJ, Horowitz SG, Katzman R. Heart conditioned medium promotes central cholinergic regeneration in vivo. Brain Research. 229: 541-6. PMID 7306826 DOI: 10.1016/0006-8993(81)91019-2  0.68
1981 Papavasiliou PS, Miller ST, Thal LJ, Nerder LJ, Houlihan G, Rao SN, Stevens JM. Age-related motor and catecholamine alterations in mice on levodopa supplemented diet. Life Sciences. 28: 2945-52. PMID 7266258 DOI: 10.1016/0024-3205(80)90326-4  0.68
1981 Sharpless NS, Tyce GM, Thal LJ, Waltz JM, Tabaddor K, Wolfson LI. Free and conjugated dopamine in human ventricular fluid. Brain Research. 217: 107-18. PMID 7260611  0.4
1980 Thal LJ, Horowitz SG, Dvorkin B, Makman MH. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging. Brain Research. 192: 185-94. PMID 7378779  0.6
1980 Makman MH, Ahn HS, Thal LJ, Sharpless NS, Dvorkin B, Horowitz SG, Rosenfeld M. Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with aging. Brain Research. 192: 177-83. PMID 7378778  0.6
1980 Thal LJ, Sharpless NS, Wolfson L, Katzman R. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations. Annals of Neurology. 7: 570-6. PMID 6969054 DOI: 10.1002/ana.410070611  0.68
1980 Makman MH, Dvorkin B, Horowitz SG, Thal LJ. Properties of dopamine agonist and antagonist binding sites in mammalian retina. Brain Research. 194: 403-18. PMID 6770965  0.6
1980 Rosenfeld MR, Makman MH, Ahn HS, Thal LJ, Mishra RK, Katzman R. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors. Advances in Biochemical Psychopharmacology. 23: 83-93. PMID 6249092  0.68
1980 Makman MH, Dvorkin B, Horowitz SG, Thal LJ. Retina contains guanine nucleotide sensitive and insensitive classes of dopamine receptors. European Journal of Pharmacology. 63: 217-22. PMID 6155277  0.6
1979 Makman MH, Ahn HS, Thal LJ, Sharpless NS, Dvorkin B, Horowitz SG, Rosenfeld M. Aging and monoamine receptors in brain. Federation Proceedings. 38: 1922-6. PMID 218850  0.6
1978 Makman MH, Ahn HS, Thal LJ, Dvorkin B, Horowitz SG, Sharpless NS, Rosenfeld M. Biogenic amine-stimulated adenylate cyclase and spiroperidol-binding sites in rabbit brain: evidence for selective loss of receptors with aging. Advances in Experimental Medicine and Biology. 113: 211-30. PMID 753089  0.6
1978 Thal LJ, Makman MH, Ahn HS, Mishra RK, Horowitz SG, Dvorkin B, Katzman R. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions. Life Sciences. 23: 629-33. PMID 99609 DOI: 10.1016/0024-3205(78)90044-9  0.68
1976 Kaufman DM, Thal LJ, Farmer PM. Central nervous system aspergillosis in two young adults. Neurology. 26: 484-8. PMID 944399  0.68
Show low-probability matches.